ENTYVIO Ā® (Vedolizumab) for Bowel Disease: Key Features and Benefits ENTYVIO Ā® (vedolizumab) is a humanized monoclonal antibody that selectively targets Ī±4Ī²7 integrin to reduce gastrointestinal inflammation, particularly in bowel diseases such as ulcerative colitis (UC) and Crohnās disease (CD). It is commonly used for patients with moderate to severe inflammatory bowel disease (IBD …
FBI Reform - fbireform.comFBI Reform - fbireform.com - The News And Times